Sophie Zander
Image of Sophie Zander

Sophie Zander

Associate

Email

sophie.zander@aoshearman.com

Phone

+1 212 848 7374

Offices

New York

V-CARD
Sophie specializes in advising clients on the intellectual property, data privacy and technology aspects of transactional matters, including mergers and acquisitions, corporate financings, capital markets offerings and licensing and collaboration arrangements.

Sophie has extensive experience drafting and negotiating a wide range of transactional documents relating to intellectual property and technology, including license agreements, software agreements, development and manufacturing agreements, service agreements, assignment agreements, credit agreements, security agreements, offering memoranda, stock and asset purchase agreements, and ancillary documents that are essential to the successful completion of corporate transactions.

Sophie’s experience spans a diverse range of industries, including life sciences, software, entertainment and media, telecommunications, artificial intelligence, automotive, energy, food and beverage, aerospace and defense, and financial services.

Expertise

Industries

Experience

Representative matters

  • Representation of The Dow Chemical Company in its $130 billion transaction with DuPont involving the combination of the two companies and their separation into three publicly traded entities.
  • Representation of Raytheon in connection with its combination with United Technologies in a merger of equals.
  • Representation of Discovery in connection with the separation of its UKTV joint venture with BBC Studios.
  • Representation of Ardagh Group in connection with its agreement to combine its Food & Specialty Metal Packaging business with Exal Corporation to create a global packaging company.
  • Representation of Boston Scientific in connection with its sale of its drug-eluting and bland embolizing bead business to Varian Medical Systems.
  • Representation of Intapp in connection with its acquisition of DealCloud.
  • Representation of Goldman Sachs in connection with its acquisition of OMH-HealthEdge Holdings and Omega Whitespace Health.
  • Representation of Baring Private Equity Asia in connection with its acquisition of AGS Health.
  • Representation of Stone Point Capital in connection with the sale of its portfolio company, Hodges-Mace, to Alight Solutions.
  • Representation of Goldman Sachs, Citigroup, and other initial purchasers in connection with Harsco's high yield notes offering.
  • Representation of Ecopetrol in connection with its joint venture with Occidental Petroleum Corporation.
  • Representation of Abertis Infraestructuras, S.A. on signing definitive agreements for the acquisition of a majority stake in Red de Carreteras de Occidente, S.A.B. de C.V.
  • Representation of the underwriters of Galera Therapeutics' initial public offering.
  • Representation of Credit Suisse, as administrative agent, on a financing for Upland Software.
  • Representation of Advanced Disposal Services in the sale of all its outstanding shares to Waste Management, Inc.

Qualifications

Admissions

Attorney-at-law, State of New York, US

Academic

BA, cum laude, Ursinus College

JD, New York University School of Law

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.